CVAT vs IVPR
Cavitation Technologies, Inc. and Inspire Veterinary Partners, Inc., side by side — 3 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | CVAT | IVPR |
|---|---|---|
| Revenue | $3,000 | $16.6M |
| Net income | $-1.4M | $-14.3M |
| Gross margin | 100.0% | · |
| Net margin | · | −86.0% |
| Return on equity | · | · |
| Diluted EPS | $0.00 | · |
| Dividend / share | · | · |
| Payout ratio | · | · |
| Free cash flow | · | $-10.2M |
| Equity | $-693,000 | $1.6M |
| Net debt / equity | · | 7.34× |
| Current ratio | 0.06× | 0.25× |
| Revenue CAGR 5y | −64.6% | · |
| Profit CAGR 5y | · | · |
IVPR bills 5530.7× the revenue of CVAT, and both closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
3 years side by side
| Fiscal year | CVAT | IVPR |
|---|---|---|
| FY2024 | $203,000 | $16.6M |
| FY2023 | $1.4M | $16.7M |
| FY2022 | $433,000 | $9.8M |
Bottom line
| Fiscal year | CVAT | IVPR |
|---|---|---|
| FY2024 | $-113,000 | $-14.3M |
| FY2023 | $439,000 | $-14.8M |
| FY2022 | $-2.0M | $-4.9M |
Standard deviation, each side
CVAT's net margin has been more volatile than IVPR's over the 3 comparable fiscal years — 219.5 percentage points of standard deviation against 17.7.
3 of 15 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between CVAT and IVPR over these 3 fiscal years — CVAT led in 2 and IVPR in 1.
3 of 15 comparable fiscal years — a year missing data on either side is not counted.